FierceBiotechOriginal article
{"a":[{"_":"Aura lays off 20% of workforce, rejigs C-suite amid R&D refocus on eye cancer","$":{"href":"/biotech/aura-lays-20-staff-rejigs-c-suite-amid-rd-refocusing","hreflang":"en"}}]}
Negative
AI Analysis
Summary
Aura Biosciences is laying off 20% of its workforce and restructuring its C-suite under new leadership as it refocuses on ocular oncology research and development.
Importance:3/10
Sentiment:
-0.60
workforce_reductionrestructuringmanagement_changeR&D_refocusocular_oncology
Related Companies
Read the original article
Published by FierceBiotech on August 11, 2026 8:18 AM
